How do you decide on a salvage regimen for relapsed/refractory DLBCL, assuming a patient is transplant eligible?

There are multiple options that carry a category 2B recommendation in the NCCN guidelines. Does germinal B center type vs activated B-cell type play a role?

Answer from: Medical Oncologist at Community Practice

Outside the context of a clinical trial, I typically use RICE or RDHAX for transplant eligible relapsed/refractory DLBCL. BioCORAL gave a signal that GCB like DLBCL may have better responses with RDHAX (Thieblemont, JCO, 2011), but I haven't seen the data repeated in other studies. If a patient has ...

Related Questions